Gladinet, Inc. – Trademark Portfolio

Entity Type: 03

Gladinet, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include TRIOFOX, GLADINET, and CENTRESTACK. The owner is based in Boca Raton, FL.

6001 Broken Sound Pkwy, Suite 508

Boca Raton, FL 33487

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Gladinet, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (5 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Gladinet, Inc. have?

Gladinet, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.

What trademark classes does Gladinet, Inc. file in?

Gladinet, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Gladinet, Inc.'s most well-known trademarks?

Gladinet, Inc.'s registered trademark portfolio includes well-known marks such as TRIOFOX, GLADINET, and CENTRESTACK. These are among 5 currently registered trademarks in the portfolio.

What is Gladinet, Inc.'s trademark registration success rate?

Gladinet, Inc. has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.